Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01115673 · ClinicalTrials.gov registry record · Phase 3

To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery

A Phase 3 study of Pain, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

Completed
Registry status
Phase 3
Development phase
540
Enrollment target
1
Study location

NCT01115673: Completed Phase 3 study of Pain, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

NCT01115673 is a Phase 3 study of Pain that has completed, run by McNeil Consumer Healthcare Division of McNEIL-PPC. The registered enrollment target is 540 participants, above the 303-participant average among 374 other Pain trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01115673, a Phase 3 study of Pain, has completed, sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC.

COMPLETED
Registry status
Phase 3
Development phase
540 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.

Conditions Studied

Interventions

  • DRUG Acetaminophen
  • DRUG Placebo Control

Study Locations (1)

Utah

  • Jean Brown Research - Salt Lake City

Trial Details

FieldValue
Enrollment Target 540 participants
Start Date 2010-06
Est. Completion 2011-01
Phase Phase 3

What the Registry Record Tells You About NCT01115673

The ClinicalTrials.gov registry entry for NCT01115673 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 303-participant average among 374 other Pain trials with a reported enrollment target (78% higher). The listed sponsor is McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Acetaminophen is the first listed.

NCT01115673 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.

Frequently Asked Questions

What is clinical trial NCT01115673 about?

NCT01115673 is a clinical study titled "To Evaluate the Safety and Efficacy of Acetaminophen 650 mg and 1000mg in Dental Pain After Surgery". The objective of this study is to evaluate the safety and efficacy of acetaminophen 650 mg and acetaminophen 1000 mg in dental surgery.

What is the current status of trial NCT01115673?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 540 participants. The study started on 2010-06. Estimated completion is 2011-01.

What conditions does trial NCT01115673 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT01115673?

The interventions under investigation include: Acetaminophen (DRUG), Placebo Control (DRUG).

Who is sponsoring clinical trial NCT01115673?

This trial is sponsored by McNeil Consumer Healthcare Division of McNEIL-PPC, which has 6 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01115673 being conducted?

This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.